Editor(s):
(1) Dr. Koteshwara Mudigonda, Propharmex Company, India.
Reviewers:
(1) K Ishizawa, Saitama Medical University Moroyama Campus, Japan.
(2) Jes Paul, Albany Medical Center, USA.
Additional Reviewers:
Open Peer Review Policy: Click Here
Specific Comment:
Average Peer review marks at initial stage: 6.5/10
Average Peer review marks at publication stage: 8.5/10
Peer Review History:
Stage 1 | Original Manuscript | File 1 | NA
Stage 2 | Peer review report_1 (K Ishizawa, Japan) | File 1 | NA
Stage 2 | Peer review report_2 (Jes Paul, USA) | File 1 | NA
Stage 2 | Revised_MS_v1_and_Feedback_v1 | File 1 | File 2
Stage 3 | Comment_Editor_1_v1 | File 1 | NA